☆ 4.7 Article

Low adherence to the guideline for the acute treatment of migraine

SCIENTIFIC REPORTS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Review Pharmacology & Pharmacy

Pharmacological strategies to treat attacks of episodic migraine in adults

Peer Tfelt-Hansen

Summary: The delay in the onset of action of acute migraine drugs is a major obstacle in successful treatment, and further investigation into the mechanisms of this delay is crucial for improving efficacy. Non-oral administration of antimigraine drugs to achieve early absorption should be explored to potentially increase maximum effect.

EXPERT OPINION ON PHARMACOTHERAPY (2021)

添加到收藏夹

Article Clinical Neurology

Twenty-five years of triptans - a nationwide population study

Olafur B. Davidsson et al.

Summary: Over a 25-year period, triptan use in Denmark has increased, but patient adherence remains low, likely due to disappointing efficacy and/or unpleasant side effects. Triptan discontinuation rates are high, indicating poor implementation of clinical guidelines.

CEPHALALGIA (2021)

添加到收藏夹

Article Clinical Neurology

Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020

Henrik W. Schytz et al.

Summary: The Danish Headache Society has launched a third version of the guidelines for the diagnosis, organization, and treatment of the most common types of headaches and facial pain, aiming to educate and advocate for the needs of patients. The guidelines provide information on examining and diagnosing headache patients, organizing headache treatment, as well as characteristics, diagnosis, and treatment for each common type of headache disorders.

JOURNAL OF HEADACHE AND PAIN (2021)

添加到收藏夹

Article Clinical Neurology

Triptanophobia in migraine: A case-control study on the causes and consequences of the nonuse of triptans in chronic migraine patients

Enrique Martinez-Pias et al.

Summary: The study found that three-quarters of chronic migraine patients did not use triptans, and nonuse of triptans was not solely due to tolerability, frequency of contraindications, or vascular risk factors. Triptan users consumed symptomatic medications fewer days per month, were under prophylactic treatment more frequently, and had medication overuse headache less frequently compared to triptan naive patients.

EXPERT REVIEW OF NEUROTHERAPEUTICS (2021)

添加到收藏夹

Article Clinical Neurology

Proposed new diagnostic criteria for chronic migraine

Mona Ameri Chalmer et al.

CEPHALALGIA (2020)

添加到收藏夹

Article Public, Environmental & Occupational Health

Patterns of initial migraine treatment in Denmark: A population-based study

Reimar Wernich Thomsen et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)

添加到收藏夹

Article Clinical Neurology

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Jes Olesen

CEPHALALGIA (2018)

添加到收藏夹

Article Clinical Neurology

Poor medical care for people with migraine in Europe - evidence from the Eurolight study

Zaza Katsarava et al.

JOURNAL OF HEADACHE AND PAIN (2018)

添加到收藏夹

Article Clinical Neurology

Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis

Kristian Thorlund et al.

CEPHALALGIA (2014)

添加到收藏夹

Review Medicine, General & Internal

Sumatriptan (all routes of administration) for acute migraine attacks in adults - overview of Cochrane reviews

Christopher J. Derry et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)

添加到收藏夹

Article Clinical Neurology

Taking the Negative View of Current Migraine Treatments The Unmet Needs

Peer Tfelt-Hansen et al.

CNS DRUGS (2012)

添加到收藏夹

Letter Hematology

The Danish Blood Donor Study: a large, prospective cohort and biobank for medical research

O. B. Pedersen et al.

VOX SANGUINIS (2012)

添加到收藏夹

Article Clinical Neurology

Migraine headache recurrence:: Relationship to clinical, pharmacological, and pharmacokinetic properties of triptans

G Géraud et al.

HEADACHE (2003)

添加到收藏夹

Review Clinical Neurology

Triptans (serotonin, 5-HT1B/1D agonists) in migraine:: detailed results and methods of a meta-analysis of 53 trials

MD Ferrari et al.

CEPHALALGIA (2002)

添加到收藏夹

Review Medicine, General & Internal

Drug therapy: Migraine - Current understanding and treatment.

PJ Goadsby et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.